Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints value and access manager

Christine Rowland joins from Pfizer
ABPI_Christine-Rowland

Christine Rowland has been appointed to the newly created position of value and access manager at the Association of the British Pharmaceutical Industry (ABPI).

Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access.

Rowland joins the ABPI from Pfizer where she spent 12 years in a range of roles, including sales, marketing, and market access, covering areas such as oncology and rare diseases. In addition to 17 years in the pharmaceutical industry, Rowland spent a decade with the NHS as a nurse and midwife.

“I am delighted to join the ABPI at this time of great change in the landscape of the UK health system and the NHS,” Rowland said.

The new role will see her join the ABPI's 23-strong commercial department. ABPI director of value and access Paul Catchpole said Rowland was a very welcome addition to the team at a time when the APPI is leading an increasing number of commercial initiatives.

“These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for greater use of newer medicines,” added Catchpole.

15th May 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics